Baiya Phytopharm Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Baiya Phytopharm Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19 (NCT05873374) | Baiya Phytopharm Co., Ltd. | 2023-12-01 |
| Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease (NCT05197712) | Baiya Phytopharm Co., Ltd. | 2022-03-28 |
| A Study to Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19 (NCT04953078) | Baiya Phytopharm Co., Ltd. | 2021-09-11 |
Track Baiya Phytopharm Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.